BIOA
BioAge Labs, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:57 PM EST
4.78USD-6.738%(-0.34)640,564
Pre-marketNov 19, 2026 9:07:30 AM EST
4.6212USD-3.221%(-0.1538)
After-hoursNov 18, 2026 4:26:30 PM EST
4.77USD-0.105%(-0.01)
BIOA News
New three-year real-world data on Leqembi® presented at CTAD 2026 ·
Cision+2 sources
BioAge Labs at UBS conference: pivots BGE-102 toward eye disease ·
Investing.com
Leqembi® Pen subcutaneous treatment launched in Japan ·
PR Newswire+1 source